759 related articles for article (PubMed ID: 20223784)
21. Designing a series of decision-theoretic phase II trials in a small population.
Hee SW; Stallard N
Stat Med; 2012 Dec; 31(30):4337-51. PubMed ID: 22927289
[TBL] [Abstract][Full Text] [Related]
22. A bayesian dose-finding design adapting to efficacy and tolerability response.
Padmanabhan SK; Berry S; Dragalin V; Krams M
J Biopharm Stat; 2012; 22(2):276-93. PubMed ID: 22251174
[TBL] [Abstract][Full Text] [Related]
23. A bayesian approach to the design of phase II clinical trials.
Sylvester RJ
Biometrics; 1988 Sep; 44(3):823-36. PubMed ID: 3203131
[TBL] [Abstract][Full Text] [Related]
24. Bayesian sample size determination in non-sequential clinical trials: Statistical aspects and some regulatory considerations.
Grouin JM; Coste M; Bunouf P; Lecoutre B
Stat Med; 2007 Nov; 26(27):4914-24. PubMed ID: 17559054
[TBL] [Abstract][Full Text] [Related]
25. Release of data from an ongoing randomized clinical trial for sample size adjustment or planning.
Freidlin B; Korn EL
Stat Med; 2007 Sep; 26(22):4074-82. PubMed ID: 17328095
[TBL] [Abstract][Full Text] [Related]
26. A predictive Bayesian approach to the design and analysis of bridging studies.
Gould AL; Jin T; Zhang LX; Wang WW
J Biopharm Stat; 2012 Sep; 22(5):916-34. PubMed ID: 22946940
[TBL] [Abstract][Full Text] [Related]
27. Approximately optimal designs for phase II clinical studies.
Stallard N
J Biopharm Stat; 1998 Jul; 8(3):469-87. PubMed ID: 9741860
[TBL] [Abstract][Full Text] [Related]
28. A Bayesian predictive sample size selection design for single-arm exploratory clinical trials.
Teramukai S; Daimon T; Zohar S
Stat Med; 2012 Dec; 31(30):4243-54. PubMed ID: 22807115
[TBL] [Abstract][Full Text] [Related]
29. Performance and sample size requirements of Bayesian methods for binary outcomes in fixed-dose combination drug studies.
Holt MM; Stamey JD; Seaman JW; Young DM
J Biopharm Stat; 2009; 19(1):120-32. PubMed ID: 19127471
[TBL] [Abstract][Full Text] [Related]
30. Sample size estimation: an overview with applications to orthodontic clinical trial designs.
Pandis N; Polychronopoulou A; Eliades T
Am J Orthod Dentofacial Orthop; 2011 Oct; 140(4):e141-6. PubMed ID: 21967951
[TBL] [Abstract][Full Text] [Related]
31. The sample size for a clinical trial: a Bayesian-decision theoretic approach.
Halpern J; Brown BW; Hornberger J
Stat Med; 2001 Mar; 20(6):841-58. PubMed ID: 11252007
[TBL] [Abstract][Full Text] [Related]
32. Practical Bayesian design and analysis for drug and device clinical trials.
Hobbs BP; Carlin BP
J Biopharm Stat; 2008; 18(1):54-80. PubMed ID: 18161542
[TBL] [Abstract][Full Text] [Related]
33. Sample-size calculations for trials that inform individual treatment decisions: a 'true-choice' approach.
Girling AJ; Lilford RJ; Braunholtz DA; Gillett WR
Clin Trials; 2007; 4(1):15-24. PubMed ID: 17327242
[TBL] [Abstract][Full Text] [Related]
34. Bayesian sample size calculation for estimation of the difference between two binomial proportions.
Pezeshk H; Nematollahi N; Maroufy V; Marriott P; Gittins J
Stat Methods Med Res; 2013 Dec; 22(6):598-611. PubMed ID: 21436190
[TBL] [Abstract][Full Text] [Related]
35. Design of adaptive two-stage double-arm clinical trials for dichotomous variables.
Jiang Z; Xue F; Li C; Wang L; Cai H; Zhang C; Xia J
Contemp Clin Trials; 2010 May; 31(3):242-50. PubMed ID: 20172053
[TBL] [Abstract][Full Text] [Related]
36. Bayesian sample size determination under hypothesis tests.
Zhang X; Cutter G; Belin T
Contemp Clin Trials; 2011 May; 32(3):393-8. PubMed ID: 21199689
[TBL] [Abstract][Full Text] [Related]
37. Sample size planning with the cost constraint for testing superiority and equivalence of two independent groups.
Guo JH; Chen HJ; Luh WM
Br J Math Stat Psychol; 2011 Nov; 64(3):439-61. PubMed ID: 20704777
[TBL] [Abstract][Full Text] [Related]
38. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
Lui KJ; Chang KC
Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
[TBL] [Abstract][Full Text] [Related]
39. A seamless phase II/III design with sample-size re-estimation.
Bischoff W; Miller F
J Biopharm Stat; 2009 Jul; 19(4):595-609. PubMed ID: 20183428
[TBL] [Abstract][Full Text] [Related]
40. A Bayesian adaptive design for multi-dose, randomized, placebo-controlled phase I/II trials.
Xie F; Ji Y; Tremmel L
Contemp Clin Trials; 2012 Jul; 33(4):739-48. PubMed ID: 22426247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
